저용량 브로모크립틴 치료로 반복적인 정상 임신과 종양 감퇴를 보인 거대프로락틴선종 1예
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최혜정 | - |
dc.contributor.author | 박진용 | - |
dc.contributor.author | 김희영 | - |
dc.contributor.author | 서지아 | - |
dc.contributor.author | 김신곤 | - |
dc.contributor.author | 김난희 | - |
dc.contributor.author | 최경묵 | - |
dc.contributor.author | 백세현 | - |
dc.contributor.author | 최동섭 | - |
dc.contributor.author | 최우석 | - |
dc.contributor.author | 송종규 | - |
dc.date.accessioned | 2021-09-08T21:56:12Z | - |
dc.date.available | 2021-09-08T21:56:12Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/121072 | - |
dc.description.abstract | Prolactin-secreting adenomas are the most common pituitary tumors. Menstrual disturbances and infertility are the main complaints in women with prolactinoma. Dopaminergic agonists such as bromocriptine are well-established treatments for prolactinoma when pregnancy is desired. Pregnancy-related outcomes in macroprolactinoma are worse than those in microprolactinoma. In addition, symptomatic tumor expansion during pregnancy occurs in 30% of women with macroprolactinoma. Therefore, when women with macroprolactinoma are planning a pregnancy, serum prolactin level should be normalized and the tumor volume significantly reduced. On the other hand, a spontaneous regression of macroprolactinoma can occur after pregnancy. We report a case of macroprolactinoma showing significant tumor regression during repeated pregnancies and low dose bromocriptine treatment, with a literature review. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 대한내분비학회 | - |
dc.title | 저용량 브로모크립틴 치료로 반복적인 정상 임신과 종양 감퇴를 보인 거대프로락틴선종 1예 | - |
dc.title.alternative | Normal Repetitive Pregnancies and Tumor Regression Induced by Low-Dose Bromocriptine in a Patient with Macroprolactinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김신곤 | - |
dc.contributor.affiliatedAuthor | 최동섭 | - |
dc.identifier.bibliographicCitation | Endocrinology and Metabolism, v.24, no.1, pp.42 - 46 | - |
dc.relation.isPartOf | Endocrinology and Metabolism | - |
dc.citation.title | Endocrinology and Metabolism | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 42 | - |
dc.citation.endPage | 46 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001332254 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Bromocriptine | - |
dc.subject.keywordAuthor | macroprolactinoma | - |
dc.subject.keywordAuthor | pregnancy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.